Latest Articles

Publication Date
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - BIOENGINEER.ORG

Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment BIOENGINEER.ORG

Published: Jan. 19, 2026, 3:06 p.m.
Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment - Bioengineer.org

Disrupting CD47-HCK-LGALS9 Axis Boosts Endometrial Cancer Treatment Bioengineer.org

Published: Jan. 19, 2026, 3:06 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!